Borrelidin has limited anti-cancer effects in bcl-2 overexpressing breast cancer and leukemia cells and reveals toxicity in non-malignant breast epithelial cells

Journal of Applied Toxicology

Volumn 34, Issue 10, 2014, Pages 1109-1113

  Gafiuc, Diana ^a   Weiß, Marlene ^a   Mylonas, Ioannis ^a   Brüning, Ansgar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bcl 2; Borrelidin; Breast cancer; Leukemia; Neoangiogenesis

Indexed keywords

BORRELIDIN; PROTEIN BCL 2; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC ANTIBIOTIC; FATTY ALCOHOL; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; BREAST; BREAST NEOPLASMS; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENETICS; METABOLISM; PROTO ONCOGENE; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; EPITHELIAL CELLS; FATTY ALCOHOLS; FEMALE; GENES, BCL-2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKEMIA; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84905042373     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2946     Document Type: Article

References (20)

1. Acharya BR, Bhattacharyya S, Choudhury D, Chakrabarti G. 2011. The microtubule depolymerizing agent naphthazarin induces both apoptosis and autophagy in A549 lung cancer cells. Apoptosis 16:924-939.
2. Azcárate IG, Marín-García P, Camacho N, Pérez-Benavente S, Puyet A, Diez A, Ribas de Pouplana L, Bautista JM. 2013. Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin. Br. J. Pharmacol. 169:645-658.
3. Berger J, Jampolsky LM, Goldberg MW. 1949. Borrelidin, a new antibiotic with antiborrelia activity and penicillin enhancement properties. Arch. Biochem. 22:476-478.
4. Bhikshapathi DVRN, Shravan Kumar Y, Madhusudan Rao Y, Kishan V. 2010. Borrelidin: a prospective drug. Ind. J. Biotech. 9:18-23.
5. Brüning A, Rahmeh M, Gingelmaier A, Friese K. 2010. The mitochondria-independent cytotoxic effect of nelfinavir on leukemia cells can be enhanced by sorafenib-mediated mcl-1 downregulation and mitochondrial membrane destabilization. Mol. Cancer 9:19.
6. Buck, M, Farr AC, Schnitzer RJ. 1949. The anti-borrelia effect of borrelidin. Trans. NY Acad. Sci. 11:207-210.
7. Edgell CJ, McDonald CC, Graham JB. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U. S. A. 80:3734-3737.
8. Gao YM, Wang XJ, Zhang J, Li M, Liu CX, An J, Jiang L, Xiang WS. 2012. Borrelidin, a potent antifungal agent: insight into the antifungal mechanism against Phytophthora sojae. J. Agric. Food Chem. 60:9874-9881.
9. Habibi D, Ogloff N, Jalili RB, Yost A, Weng AP, Ghahary A, Ong CJ. 2012. Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia. Invest. New Drugs 30:1361-1370.
10. Ishiyama A, Iwatsuki M, Namatame M, Nishihara-Tsukashima A, Sunazuka T, Takahashi Y, Omura S, Otoguro K. 2011. Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum. J. Antibiot. (Tokyo) 64:381-384.
11. Kawamura T, Liu D, Towle MJ, Kageyama R, Tsukahara N, Wakabayashi T, Littlefield BA. 2003. Anti-angiogenesis effects of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells. J. Antibiot. (Tokyo) 56:709-715.
12. Lee HJ, Burger P, Vogel M, Friese K, Brüning A. 2012. The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells. Invest. New Drugs 30:1917-1925.
13. Mahamodhossen YA, Liu W, Rong-Rong Z. 2013. Triple-negative breast cancer: new perspectives for novel therapies. Med. Oncol. 30:653.
14. Martin SS, Leder P. 2001. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol. Cell. Biol. 21:6529-6536.
15. Ruan B, Bovee ML, Sacher M, Stathopoulos C, Poralla K, Francklyn CS, Söll D. 2005. A unique hydrophobic cluster near the active site contributes to differences in borrelidin inhibition among threonyl-tRNA synthetases. J. Biol. Chem. 280:571-577.
16. Sekine I, Shimizu C, Nishio K, Saijo N, Tamura T. 2009. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer. Int. J. Clin. Oncol. 14:112-119.
17. Sugawara A, Tanaka T, Hirose T, Ishiyama A, Iwatsuki M, Takahashi Y, Otoguro K, Omura S, Sunazuka T. 2013. Borrelidin analogues with antimalarial activity: design, synthesis and biological evaluation against Plasmodium falciparum parasites. Bioorg. Med. Chem. Lett. 23:2302-2305.
18. Thomadaki H, Scorilas A. 2006. BCL2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit. Rev. Clin. Lab. Sci. 43:1-67.
19. Wakabayashi T, Kageyama R, Naruse N, Tsukahara N, Funahashi Y, Kitoh K, Watanabe Y. 1997. Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model. J. Antibiot. (Tokyo) 50:671-676.
20. Wilkinson B, Gregory MA, Moss SJ, Carletti I, Sheridan RM, Kaja A, Ward M, Olano C, Mendez C, Salas JA, Leadlay PF, vanGinckel R, Zhang MQ. 2006. Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain. Bioorg. Med. Chem. Lett. 16:5814-5817.